CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease
Parkinson's disease (PD) and other chronic and debilitating neurodegenerative diseases (NDs) impose a substantial medical, emotional, and financial burden on individuals and society. The origin of PD is unknown due to a complex combination of hereditary and environmental risk factors. However,...
Saved in:
Main Authors: | Mujeeb ur Rahman (Author), Muhammad Bilal (Author), Junaid Ali Shah (Author), Ajeet Kaushik (Author), Pierre-Louis Teissedre (Author), Małgorzata Kujawska (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017) -
CRISPR/Cas9-mediated genome editing in nonhuman primates
by: Yu Kang, et al.
Published: (2019) -
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
by: Nan Liu, et al.
Published: (2022) -
HDAC inhibitors improve CRISPR-Cas9 mediated prime editing and base editing
by: Nan Liu, et al.
Published: (2022) -
Gene editing and therapy - A new tool: CRISPR/Cas9
by: Ashok M. Patil
Published: (2019)